381677-75-4 Usage
Uses
Used in Pharmaceutical Industry:
4-(3-fluorophenyl)dihydro-2H-pyran-2,6(3H)-dione is used as a therapeutic agent for its antioxidant, anti-inflammatory, and anti-cancer properties. It is being investigated for its potential in treating various health conditions, such as allergies, asthma, and cardiovascular diseases, due to its ability to protect cells from oxidative stress and inflammation, as well as inhibit the growth of cancer cells.
Used in Nutraceutical Industry:
4-(3-fluorophenyl)dihydro-2H-pyran-2,6(3H)-dione is used as a health-promoting ingredient in nutraceutical products. Its antioxidant, anti-inflammatory, and anti-cancer properties make it a valuable addition to dietary supplements and functional foods, aiming to support overall health and well-being.
Used in Cosmetic Industry:
4-(3-fluorophenyl)dihydro-2H-pyran-2,6(3H)-dione is used as an active ingredient in cosmetic products for its antioxidant and anti-inflammatory properties. It can help protect the skin from oxidative stress and inflammation, promoting a healthy and youthful appearance.
Used in Food Industry:
4-(3-fluorophenyl)dihydro-2H-pyran-2,6(3H)-dione is used as a natural preservative and flavor enhancer in the food industry. Its antioxidant properties can help extend the shelf life of food products, while its unique taste profile can enhance the flavor of various dishes.
Check Digit Verification of cas no
The CAS Registry Mumber 381677-75-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,1,6,7 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 381677-75:
(8*3)+(7*8)+(6*1)+(5*6)+(4*7)+(3*7)+(2*7)+(1*5)=184
184 % 10 = 4
So 381677-75-4 is a valid CAS Registry Number.
381677-75-4Relevant academic research and scientific papers
Synthesis of 2,5-thiazole butanoic acids as potent and selective αvβ3 integrin receptor antagonists with improved oral pharmacokinetic properties
Wendt, John A.,Wu, Hongwei,Stenmark, Heather G.,Boys, Mark L.,Downs, Victoria L.,Penning, Thomas D.,Chen, Barbara B.,Wang, Yaping,Duffin, Tiffany,Finn, Mary Beth,Keene, Jeffery L.,Engleman, V. Wayne,Freeman, Sandra K.,Hanneke, Melanie L.,Shannon, Kristen E.,Nickols, Maureen A.,Steininger, Christina N.,Westlin, Marissa,Klover, Jon A.,Westlin, William,Nickols, G. Allen,Russell, Mark A.
, p. 845 - 849 (2007/10/03)
We describe a series of 2,5 thiazole containing compounds, which are potent antagonists of the integrin αvβ3 and show selectivity relative to the other integrins, such as αIIbβ 3 and αvβ6. These analogs were demonstrated to have high bioavailability relative to other relative heterocyclic analogs.
